View in EDS HTML Full Text PDF Full Text

Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer.

Saved in:
Bibliographic Details
Title: Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer.
Authors: Mugnier, L.1 (AUTHOR), Espitalier, F.1 (AUTHOR), Menegotto, J.2 (AUTHOR), Bell, S.3 (AUTHOR), Ré, M. I.1 (AUTHOR)
Source: Pharmaceutical Development & Technology. Sep2023, Vol. 28 Issue 7, p697-707. 11p.
Database: Business Source Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: bsu
DbLabel: Business Source Ultimate
An: 170023159
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Mugnier%2C+L%2E%22">Mugnier, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Espitalier%2C+F%2E%22">Espitalier, F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Menegotto%2C+J%2E%22">Menegotto, J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bell%2C+S%2E%22">Bell, S.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ré%2C+M%2E+I%2E%22">Ré, M. I.</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pharmaceutical+Development+%26+Technology%22">Pharmaceutical Development & Technology</searchLink>. Sep2023, Vol. 28 Issue 7, p697-707. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=bsu&AN=170023159
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10837450.2023.2233612
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 697
    Titles:
      – TitleFull: Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mugnier, L.
      – PersonEntity:
          Name:
            NameFull: Espitalier, F.
      – PersonEntity:
          Name:
            NameFull: Menegotto, J.
      – PersonEntity:
          Name:
            NameFull: Bell, S.
      – PersonEntity:
          Name:
            NameFull: Ré, M. I.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 10837450
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Pharmaceutical Development & Technology
              Type: main
ResultId 1